Promatix

Promatix is a biotechnology company focused on the development of innovative therapeutics, particularly in the field of cancer treatment. The company leverages a multi-omics platform that integrates proteomic, genomic, and transcriptomic data to discover and validate new therapeutic targets. By utilizing their TxPro technology, Promatix identifies and assesses novel drug targets at the protein level through differential protein expression analysis in both diseased and normal tissues. This approach enables Promatix to support medical companies in the discovery and validation of drug targets, enhancing the pipeline for potential cancer therapies.